Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2011 Nov 19;83(2):720–726. doi: 10.1016/j.ijrobp.2011.06.2011

Table 4.

Five-year Cumulative Local Control for Group IIA – Favorable Site Tumors N = 62, median follow-up = 4.8 years (0.2 – 9.1 years)

Protocol Rate RT Dose (Gy) Chemotherapy Local Failure
D9602 (n=62) 36 VA 15%*
IRS III (n=52) 41.4 VA 11%
IRS IV (n=43) 41.4 VAC/VAI/VAE 2%

I = ifosfamide, E = etoposide

*

Five of 8 failures in D9602 occurred in girls with non-bladder genitourinary primaries who did not receive RT.